- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hepatocellular Carcinoma Non-resectable in Hong Kong
Total 400 results
-
AstraZenecaCompletedNon-small Cell Lung CancerChina
-
SanofiTerminated
-
Chinese University of Hong KongRecruitingPancreatic Cancer Non-resectable | Pain Cancer | Tumor PancreasHong Kong
-
SCG Cell Therapy Pte. Ltd.RecruitingHepatocellular Carcinoma Recurrent | Hepatitis B Virus Related Hepatocellular CarcinomaUnited States, Singapore, Hong Kong
-
AstraZenecaCompletedCancer | Advanced Hepatocellular CarcinomaKorea, Republic of, Hong Kong
-
PfizerCompletedCarcinoma, HepatocellularKorea, Republic of, China, Taiwan, Hong Kong
-
Nam Dinh University of NursingThe Hong Kong Polytechnic UniversityCompletedLung Cancer, Nonsmall Cell | Lung Cancer Non-Small Cell Stage 0 | Lung Cancer, Nonsmall Cell, Stage I | Lung Cancer Non-Small Cell Stage II | Lung Cancer, Limited Stage Small CellHong Kong
-
Chinese University of Hong KongCompletedHIV Infections | Hepatitis B | Hepatocellular Carcinoma | Hepatitis CHong Kong
-
Hong Kong Baptist UniversityThe Queen Elizabeth HospitalTerminated
-
The University of Hong KongUnknownNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIBHong Kong
-
Chinese University of Hong KongHenan Provincial People's HospitalCompletedHepatitis B | Hepatocellular CarcinomaChina
-
National University Hospital, SingaporeAstraZeneca; Singapore Clinical Research InstituteUnknownCarcinoma, Non-Small-Cell LungTaiwan, Hong Kong, Thailand, Singapore, Korea, Republic of
-
Shanghai Pulmonary Hospital, Shanghai, ChinaThe University of Hong KongNot yet recruitingNon Small Cell Lung Cancer | Influenza VaccineChina
-
Novartis PharmaceuticalsTerminatedHepatocellular CarcinomaHong Kong, Taiwan, Thailand
-
GlaxoSmithKlineCompletedCarcinoma, HepatocellularTaiwan, United States, Hong Kong
-
AstraZenecaIonis Pharmaceuticals, Inc.CompletedAdvanced Adult Hepatocellular Carcinoma | Hepatocellular Carcinoma MetastaticKorea, Republic of, Taiwan, Hong Kong, Japan
-
GlaxoSmithKlineCompletedCarcinoma, HepatocellularTaiwan, Thailand, Hong Kong
-
Novartis PharmaceuticalsTerminatedAdvanced Hepatocellular Carcinoma With c-MET DysregulationChina, Hong Kong, Thailand, Singapore
-
Light Sciences OncologyCompletedCarcinoma, Hepatocellular | Liver NeoplasmsTaiwan, Hong Kong, Singapore
-
Galvanize Therapeutics, Inc.Active, not recruitingNon Small Cell Lung CancerHong Kong, Spain, Netherlands
-
Novartis PharmaceuticalsWithdrawnAdvanced Hepatocellular CarcinomaGermany, Australia, Hong Kong, Switzerland, Spain, France, United States
-
Ligand PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Hong Kong, Taiwan
-
AnaborexTerminatedAnorexia | Carcinoma, Non-Small-Cell Lung | Weight Loss | CachexiaChina, Taiwan
-
National Cancer Centre, SingaporeGuardant Health AMEA, Inc.RecruitingNon-small Cell Lung Cancer | ALK-Positive Lung CancerKorea, Republic of, Hong Kong, Malaysia, Singapore
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Hong Kong, Taiwan, Korea, Republic of
-
Progen PharmaceuticalsTerminatedCancer | Hepatocellular Carcinoma | Primary Liver Cancer | Liver Cancer | HepatomaHong Kong, Singapore, United States, Australia, Canada, Italy, Malaysia, Spain, Taiwan, Thailand
-
Servier Bio-Innovation LLCRegeneron Pharmaceuticals; Institut de Recherches Internationales ServierNot yet recruitingNon-small Cell Lung Cancer (NSCLC)Hong Kong, United States, Australia
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma | Recurrent Nasopharyngeal Undifferentiated Carcinoma | Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 | Adult Nasal Type Extranodal NK/T-Cell Lymphoma | Stage IV Nasopharyngeal Undifferentiated Carcinoma...United States, Singapore, Japan, Hong Kong
-
Yiviva Inc.RecruitingAdvanced Hepatocellular CarcinomaUnited States, Taiwan, China, Hong Kong
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Taiwan, Germany, Italy, Hong Kong, Canada, Japan, Spain
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationTerminatedCancer | Hepatocellular Carcinoma | Liver CancerKorea, Republic of, Taiwan, Hong Kong, China
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularUnited States, Hong Kong, Taiwan, Singapore
-
TularikUnknownHepatocellular CarcinomaUnited States, China
-
AbbottTerminatedLiver Diseases | Digestive System Diseases | Neoplasms | Neoplasms by Histologic Type | Neoplasms by Site | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Digestive System Neoplasms | Carcinoma, Hepatocellular | Liver Neoplasms | Hepatocellular Carcinoma Non-resectable | Hepatocellular Carcinoma...United States, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Czech Republic, Denmark, Egypt, France, Germany, Greece, Hong Kong, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Norway, Puerto... and more
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaChina, Taiwan, Thailand, Korea, Republic of, Hong Kong
-
Novartis PharmaceuticalsCompletedAdvanced Hepatocellular CarcinomaTaiwan, Canada, Italy, Korea, Republic of, Hong Kong, Germany, China, France
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
BayerCompletedCarcinoma, HepatocellularHong Kong, Taiwan, Korea, Republic of, Singapore
-
GC Cell CorporationCompletedHepatocellular CarcinomaKorea, Republic of
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedLung CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
Arbutus Biopharma CorporationCompletedHepatocellular Carcinoma | Hepatoma | Liver Cancer, Adult | Liver Cell Carcinoma, AdultUnited States, Taiwan, Singapore, China, Canada, Korea, Republic of
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Proacta, IncorporatedTerminatedHepatocellular CarcinomaUnited States, Taiwan, Singapore, Hong Kong
-
University of WashingtonNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Cervical Undifferentiated Carcinoma | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage... and other conditionsUnited States, Hong Kong, Canada
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaTaiwan, Hong Kong, China, Thailand, Korea, Republic of, Singapore, Japan
-
Hoffmann-La RocheCompletedCarcinoma, Hepatocellular | Liver Metastases | Biliary Tract Cancer | Secondary Liver CancerKorea, Republic of, Denmark, Spain, Taiwan, United States, Hong Kong
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerTaiwan, Korea, Republic of, Singapore, Thailand, Hong Kong